Document is current

Any future updates will be listed below

MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway

Crossref DOI link: https://doi.org/10.1038/s41598-018-26381-w

Published Online: 2018-05-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark